Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 18/20 | 0.71 |
| ▸ | PDE6C | P51160 | 3/20 | 0.71 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.71 |
| ▸ | PDE1A | P54750 | 2/20 | 0.71 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.71 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.71 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.71 |
| ▸ | PDE2A | O00408 | 1/20 | 0.71 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.71 |
| ▸ | ABCC5 | O15440 | 1/20 | 0.71 |
| ▸ | PDE6D | O43924 | 1/20 | 0.71 |
| ▸ | PDE8A | O60658 | 1/20 | 0.71 |
| ▸ | PDE9A | O76083 | 1/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | HTR1A | P08908 | 1/20 | 0.71 |
| ▸ | PDE6A | P16499 | 1/20 | 0.71 |
| ▸ | PDE6G | P18545 | 1/20 | 0.71 |
| ▸ | PDE4A | P27815 | 1/20 | 0.71 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15423769 | 0.97 | PDE5A (0.68) | PDE5APDE6CPDE3APDE1APDE1B | |
| SCHEMBL7962791 | 0.94 | PDE5A (0.64) | PDE5APDE6CPDE3APDE1APDE1B | |
| SCHEMBL17390180 | 0.92 | PDE5A (0.72) | PDE5APDE6CPDE3APDE1APDE1B | |
| SCHEMBL16003659 | 0.89 | PDE5A (0.70) | PDE5APDE6CPDE3AHDAC6HDAC1 | |
| SCHEMBL17390127 | 0.88 | PDE5A (0.75) | PDE5APDE6CPDE3AHDAC6HDAC1 | |
| SCHEMBL8281603 | 0.88 | PDE5A (0.55) | PDE5APDE6CPDE3APDE1APDE1B | |
| SCHEMBL17390135 | 0.88 | PDE5A (0.64) | PDE5APDE6CPDE3APDE3BHDAC6 | |
| SCHEMBL15071441 | 0.88 | PDE5A (0.67) | PDE5APDE6CPDE3APDE1APDE1B | |
| SCHEMBL18715171 | 0.88 | PDE5A (0.75) | PDE5APDE6CPDE3APDE1APDE1B | |
| SCHEMBL18592591 | 0.88 | PDE5A (0.68) | PDE5APDE6CPDE3APDE1APDE1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9221825-B2 | Pyrazolopyrimidinone compound and imidazo triazone compound for treating erectile dysfunction | ZHEJIANG DADE PHARMACEUTICAL GROUP CO., LTD. (CN) | 2015-12-29 | — | — | US | disclosed |
| US-20140018351-A1 | Pyrazolopyrimidinone Compound and Imidazo Triazone Compound for Treating Erectile Dysfunction | Zhejiang Date Pharmaceutical Group Co. Ltd (CN) | 2014-01-16 | — | — | US | disclosed |
| US-20110048980-A1 | Fatty Acid Oxidation Inhibitors Treating Hyperglycemia and Related Disorders | SYMCOPEIA COMPANY (US) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110048980-A1 | Fatty Acid Oxidation Inhibitors Treating Hyperglycemia and Related Disorders | PDE5A, ELOVL5, CPT1B | PDE5A 1/4885PDE6C 32/4885PDE3A 11/4885 |
| US-20140018351-A1 | Pyrazolopyrimidinone Compound and Imidazo Triazone Compound for Treating Erectile Dysfunction | PDE3A, PDE3B, PDE5A | PDE5A 3/4885PDE6C 43/4885PDE3A 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.